Hi everyone,
It's amazing - when my mom was first diagnosed with stage IIIc, it felt like everything was coming to an end. But everything you all told me in the beginning was right. We've actually continued to enjoy life in spite of cancer. It's a different kind of life and we are sad occasionally but we still have really good times. I am so proud of my mom - this is her 5th cycle and she has been so strong throughout this.
I can't believe we're almost done with the primary IP treatment.
Kathy6, you gave me wonderful advice when you told me to stay one step ahead. It has definitely helped in this process. We anticipated side effects, researched things every step of the way. It's made us feel much more in control of things.
So now, in the interest of staying one step ahead, we are trying to figure out where to go from here.
My mom does not want to just finish at this point. She says she would like to be proactive in minimizing chances of a recurrence. It's hard because there is no guarantee.
Assuming my mom still feels good after the 6th cycle, we are considering a few options. I think we are going to take a short break regardless - my mom wants to go on a family cruise and recover from all this therapy :)
1) The xyotax vs taxol vs placebo trial. I know there have been other discussion threads on this. If anyone has had any significant experiences please share.
2) Vaccine therapy - I know the mimosa trial is closed but the results are supposed to come out next year, and there may be other trials as well (there was a phase 1 trial that was posted on this site a couple days ago that looked really promising). I wonder if that might be a better option than maintenance.
We will of course discuss this with her doctor and we plan to go for a second opinion to either MD Anderson or Memorial Sloan. But if anyone has feedback, especially about the trials - please let me know.
Many, many, many thanks. You have all been a life--saver through this process. It's strange how close I feel to people I've never met :)
Anne





Add to the discussion